Egyptian Rheumatology and Rehabilitation

Table 4 Comparisons of HAQ, BASFI, and NHP by rheumatic diseases within age groups

From: Assessment of physical function, quality of life, and medication adherence in elderly patients with rheumatic diseases

	18–64 years				≥ 65 years
	AS	RA	Other rheumatic diseases	P¹	AS	RA	Other rheumatic diseases	P¹	P²	P³	P⁴
NHP pain	12.91 (0–100)	11.48 (0–100)	12.91 (0–100)	0.523	23.4 (0–59.4)	31.52 (0–100)	23.23 (0–100)	0.392	0.045	0.000	0.128
NHP emotional reaction	7.08 (0–55.78)	0 (0–63.24)	0 (0–76.25)	0.772	19.09 (0–37.98)	16.21 (0–86.25)	6.01 (0–86.25)	0.780	0.208	0.023	0.510
NHP sleep	12.57 (0–87.63)	0 (0–87.63)	0 (0–77.63)	0.650	27.26 (0–87.63)	71.42 (0–100)	0 (0–87.63)	0.071	0.133	0.001	0.915
NHP social isolation	0 (0–44.54)	0 (0–81.64)	0 (0–44.54)	0.708	19.36 (0–44.54)	9.68 (0–100)	0 (0–88.7)	0.381	0.209	0.082	0.531
NHP physical activity	10.79 (0–88.7)	9.3 (0–88.7)	0 (0–66.69)	0.754	21.99 (0–67.16)	43.41 (0–88.7)	31.22 (0–83.5)	0.457	0.028	0.001	0.066
NHP energy	0 (0–100)	0 (0–100)	24 (0–100)	0.723	36.3 (0–100)	24 (0–100)	0 (0–100)	0.343	0.043	0.075	0.581
HAQ	–	0.1 (0–0.7)	0.15 (0–0.6)	0.702	0.15 (0.05–3.6)	0.38 (0–7)	0.1 (0–0.7)	0.392		0.004
BASFI	1.7 (0.1–7.2)	–	–	–	4.9 (3.4–6.1)	–	–	–	0.001		0.728

P ≤ 0.05
¹Comparisons according to rheumatic diseases within age groups (Kruskal-Wallis test)
²Comparisons among ankylosing spondylitis patients by age group (Mann-Whitney U test)
³Comparisons among rheumatoid arthritis patients by age group (Mann-Whitney U test)
⁴Comparisons among patients with other rheumatic diseases by age group (Mann-Whitney U test), median (min-max). HAQ Health Assessment Questionnaire, BASFI Bath Ankylosing Spondylitis Functional Index
P ≤ 0.05 is considered significant

Back to article page